Westbourne Investment Advisors, Inc. Pfizer Inc Transaction History

Westbourne Investment Advisors, Inc.

$276 Million
Q2 2024

A detailed history of Westbourne Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Westbourne Investment Advisors, Inc. holds 19,810 shares of PFE stock, worth $587,564. This represents 0.2% of its overall portfolio holdings.

Number of Shares

19,810

Previous 19,810 -0.0%

Holding current value

$587,564

Previous $550,000 0.73%

% of portfolio

0.2%

Previous 0.2%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$25.89 - $29.73 $19,417 - $22,297	-750 Reduced 3.65%	19,810 $550,000
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $24,067 - $28,132	-750 Reduced 3.52%	20,560 $682,000
Q1 2022 Jun 15, 2022	BUY	$45.75 - $56.69 $2,287 - $2,834	50 Added 0.24%	21,310 $1.1 Million
Q4 2021 Jan 24, 2022	BUY	$41.32 - $61.25 $340,890 - $505,312	8,250 Added 63.41%	21,260 $1.26 Million
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $71,820 - $81,360	-2,000 Reduced 13.32%	13,010 $509,000
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $13,396 - $15,108	-400 Reduced 2.6%	15,010 $544,000
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $1,587 - $1,862	50 Added 0.33%	15,410 $566,000
Q2 2020 Jul 14, 2020	SELL	$30.12 - $36.54 $103,733 - $125,843	-3,444 Reduced 18.32%	15,360 $502,000
Q1 2020 Apr 21, 2020	SELL	$27.03 - $38.62 $29,733 - $42,482	-1,100 Reduced 5.53%	18,804 $614,000
Q4 2019 Jan 23, 2020	SELL	$32.92 - $37.36 $16,460 - $18,680	-500 Reduced 2.45%	19,904 $780,000
Q3 2019 Oct 22, 2019	BUY	$32.49 - $42.13 $18,194 - $23,592	560 Added 2.82%	20,404 $733,000
Q2 2019 Jul 22, 2019	SELL	$36.98 - $41.52 $207,087 - $232,512	-5,600 Reduced 22.01%	19,844 $860,000
Q1 2019 Apr 15, 2019	SELL	$37.5 - $41.2 $45,000 - $49,440	-1,200 Reduced 4.5%	25,444 $1.08 Million
Q4 2018 Jan 18, 2019	BUY	$38.47 - $43.86 $115,410 - $131,580	3,000 Added 12.69%	26,644 $1.16 Million
Q3 2018 Oct 18, 2018	SELL	$34.47 - $41.81 $6,894 - $8,362	-200 Reduced 0.84%	23,644 $1.04 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $26,383 - $28,127	-800 Reduced 3.25%	23,844 $865,000
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $92,539 - $107,358	-2,900 Reduced 10.53%	24,644 $875,000
Q4 2017 Jan 31, 2018	BUY	$33.26 - $35.29 $19,956 - $21,174	600 Added 2.23%	27,544 $998,000
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $835,264 - $920,137	26,944	26,944 $962,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westbourne Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westbourne Investment Advisors, Inc. with notifications on news.

Account

Westbourne Investment Advisors, Inc. Pfizer Inc Transaction History